2025年4月，国家卫健委发布了《家庭医生签约基本服务包清单（试行）》通知，"鼓励各地建立签约服 务项目库，由签约居民根据自身需求'点单'选择服务内容"。相城三院在此基础上，也进行了签约服务 的升级，增加了个性化服务包。 个性化服务包具体包括糖尿病管理个性化服务包、高血压管理个性化服务包、肺部疾病管理个性化服务 包、失能人员照护个性化服务包、体重管理专属服务包、中医特色诊疗服务包、儿童健康成长管理包、 孕产妇全程关怀服务包、口腔科专项服务包。这些服务包针对不同群体，充分满足多样化的健康服务需 求。"我们的目标是让更多辖区居民享受到有温度、有深度的基层医疗服务。"相城三院副院长朱小丁表 示。王士付 "徐老伯，最近感觉怎么样，有没有头痛头晕了？""上次你们给我检查以后，现在都挺好的，真的谢谢 你们！"这是苏州市相城区第三人民医院凤凰泾家庭医生服务团队正在为签约居民上门服务。 服务对象徐老伯今年77岁，患有高血压多年，血压控制相对稳定。上个月，徐老伯在家庭医生吴刚上门 时告诉他，自己近期时常感到头晕头痛，有时头痛剧烈。吴刚立即为徐老伯量了血压，发现他血压偏 高，又详细询问了他近期的病症和用药情况，及时为他调整了用药 ...

Core Viewpoint - The company, Saily Medical, has experienced a significant stock price increase of over 250% this year, despite reporting a tenfold increase in losses for the first half of 2025, highlighting a stark contrast between stock performance and financial results [2][9]. Financial Performance - The company expects a net loss attributable to shareholders of between 55 million to 66 million yuan for the first half of 2025, which is an increase in losses of 50.23 million to 61.23 million yuan compared to the same period last year [3]. - The first quarter of 2025 showed a net loss of 14.32 million yuan, indicating a worsening trend in the second quarter [3][6]. - Revenue for the first half of 2025 is projected to decline by 40.75% compared to the previous year, with a significant drop in net profit of 553.66% [4][6]. Business Operations - The company has been trapped in a cycle of increasing revenue without corresponding profit since 2020, with a net profit loss that has expanded for four consecutive years [4][6]. - The main business areas, particularly the SPD business, are showing signs of fatigue, with revenue growth of only 10.23% in 2024, while costs have risen nearly in tandem, leading to minimal improvement in gross margins [6][10]. Market Position and Investor Sentiment - Despite the financial struggles, Saily Medical's stock price has surged, creating a disconnect between market valuation and financial fundamentals, raising concerns about sustainability [10][14]. - Analysts suggest that the current high valuation may not be supported by the company's fundamentals, and caution against blindly following market trends without a thorough analysis of the company's core business improvements [10][14]. Strategic Direction and Challenges - The company is focusing on a transformation towards medical intelligence, including areas like brain-computer interfaces and innovative drugs, but faces skepticism regarding the feasibility and timeline of these initiatives [10][12]. - R&D investment remains low, with only 2.58% of revenue allocated to R&D in 2024, which is insufficient to support the ambitious multi-line strategy [10][12]. Financial Health and Credit Rating - Saily Medical has faced liquidity pressures, with multiple instances of overdue repayment of raised funds, leading to criticism of management [12][13]. - The company's credit rating was downgraded from "BBB-" to "BB+" due to increasing losses, long customer payment cycles, and high financial leverage, indicating a deteriorating financial outlook [14].

与社区居民共度美好时光。7月18日,齐鲁晚报·齐鲁壹点"漱玉平民杯"第十届社区文化节走进济南历下区 龙洞街道办事处财富花园社区,为市民带来便民服务和精彩演出。 文/片 刘桂斌 济南报道 欢乐是每场社区文化节不变的主题。下午五点半,文艺演出环节正式开始,小丑表演带动了全场的气氛,赢 得了现场居民的阵阵掌声。紧接着,魔术师亮相,空袋子里忽然抖出一把红包,又瞬间变出五彩丝巾,观众还 来不及眨眼,他已把掌声和惊叹声收入囊中。 社区文艺骨干轮番献艺:舒缓的太极扇与音乐喷泉交相辉映,青年合唱团的改编歌曲把现场气氛推向高潮, 压轴的集体舞更是带动全场观众一起挥动手机闪光灯,广场瞬间化作一片星海。居民宋女士抱着孙子感 慨:"不用出小区就能看演出,比在家看电视热闹多了!" 义诊＋流动办公桌 便民服务送到家门口 舞台东侧的蓝色帐篷同样人气高涨。漱玉平民大药房把"微型体检站"搬到现场,血压、血糖、骨密度检 测全部免费。专业工作人员一边操作仪器,一边叮嘱老人夏季饮食起居注意事项。 情景科普笑声不断 "反诈奶奶团"讲反诈 在泉城济南,活跃着一支平均年龄超67岁的"反诈奶奶团",从受骗者到反诈"明星",她们个个身怀"绝活",唱 歌、跳舞 ...

资料显示，沪农商行成立于2005年8月，主营业务是公司银行业务、个人银行业务、金融市场业务及其 他业务。 所属行业：银行–农商行Ⅱ–农商行Ⅲ 圣诺生物：醋酸加尼瑞克注射液获药品注册证书 7月22日晚，圣诺生物（688117）发布公告称，全资子公司成都圣诺生物制药有限公司近日收到国家药 品监督管理局签发的醋酸加尼瑞克注射液的《药品注册证书》。该药品主要用于接受辅助生殖技术 （ART）控制性卵巢刺激（COS）方案的妇女，预防过早出现促黄体激素（LH）峰。 皖通高速：中标全椒至禄口高速公路安徽段项目 7月22日晚，皖通高速（600012）发布公告称，公司收到中标通知书，确认其加入的联合体中标S98全 椒至禄口高速公路安徽段特许经营者项目。该项目采用BOT模式，中标收费期限为356个月，工期1095 天。项目全长22.46公里，估算投资50.50亿元，计划2025年底开工，2028年底建成通车。皖通高速在联 合体中持股20%。 资料显示，皖通高速成立于1996年8月，主营业务是投资、建设、运营及管理安徽省境内的部分收费公 路。 所属行业：交通运输–铁路公路–高速公路 沪农商行：副行长任职资格获批 7月22日晚，沪农商 ...

随着我国人口老龄化进程持续深化，银发消费正展现出强劲的增长势头。国家统计局数据显示，截至2024年年末，60岁及以上人口已达31031万人，占全国 人口的22.0%。这一庞大的消费群体催生了巨大的市场需求，银发经济正逐步成为推动经济增长的重要引擎。 地方政府也积极响应国家政策。广东省提出到2025年底，在智能照护机器人、智能助行器、助视器、助听器等方面形成一批"专精特新"适老化产品生产企 业，规上老年用品营业收入要达到6000亿元。天津将老年助餐服务纳入"一刻钟便民生活圈"，吉林推出"康复辅具进社区"专项行动。 银发消费需求持续升温 老年群体的消费模式正发生深刻变化，从基础生活需求向多元化、品质化消费转型。在旅游领域，银发族已成为重要的消费力量。春节期间银发群体的文旅 消费表现尤为突出，邮轮游订单同比增长357%，其中50岁以上人群订单增长近2倍。自驾游市场数据显示，银发族平均消费较其他年龄层高出7.2%。 健康养生领域同样呈现出旺盛的消费活力。随着生活水平提升，老年人对健康产品的投入意愿不断增强。国家税务总局数据显示，2025年上半年，助行助听 产品销售收入同比增长32.2%，老年营养和保健品增长30.1% ...

2025年7月14日， 九安医疗 （股票代码：002432）发布了2025年半年度业绩预告。 | 项目 | 本期报告 | 上年同期 | | --- | --- | --- | | 归属上市公司股东的净利润 | 盈利: 88,000 万元-98,000 万元 | 盈利: 60,175.95 万元 | | | 比上年同期增长:46.24%-62.86% | | | 扣除非经营性损益的净利润 | 盈利：86,000 万元-96,000 万元 | 盈利：69,754.62 万元 | | | 比上年同期增长:23.29%-37.63% | | | 基本每股收益 | 盈利: 2.0129 元/股-2.2416 元/股 | 盈利: 1.3788 元/股 | 根据公告，公司预计2025年上半年实现归属于上市公司股东的 净利润为8.8亿元至9.8亿元 ，同比 增长46.24%至62.86% ；扣非净利润预计为8.6亿元至9.6亿 元，同比增长 23.29%至37.63% ；基本每股收益预计为2.0129元/股至2.2416元/股。 iHealth蓝牙智能血压计 业绩增长原因 2025年一季度财报数据 2025年第一季度，九安医 ...

"不好用"是智慧养老产品难获好评的首要原因。尽管优势显而易见，但不少产品在研发中却经常陷入技 术与需求脱节、适老化不足的困境。譬如，有的企业过度追求参数提升，把复杂功能堆砌到老年产品 上，却忽视了基础功能的人性化设计，导致产品操作逻辑复杂、使用困难；有的终端误报率高、佩戴不 适、需要频繁充电，影响了老年人的使用体验。此外，不同品牌设备的系统割裂、数据不通，需要反复 配置，提高了老年人的操作门槛。 "叫座"的关键在于破除价格障碍，不少企业已经开始积极探索。有的通过基础功能打开市场，再通过增 值服务盈利，形成良性循环；有的主动参与地方适老化改造，让老年人在使用过程中建立品牌信任，为 后续推广奠定基础；有的建立分层产品体系，开发更具性价比的产品。只有让产品真正融入广大老年群 体的日常生活，才能在规模效应中实现商业价值与社会价值的双赢。 "叫好"的核心是解决老年人真实痛点。作为企业，应聚焦老年群体的实际需求和使用习惯，充分考虑老 年人认知功能下降、视觉听觉衰退、触控灵敏度变弱等生理特征，推出实用、易用、耐用的产品，不仅 要为老年人破解生活难题，而且要让他们能"无感使用"，不用刻意学习"高科技"。 "用不起"是智慧养老 ...

Core Viewpoint - Hanwang Technology is experiencing a mixed financial performance, with a projected revenue increase but significant net losses expected for the reporting period [2][3]. Financial Performance - The company anticipates a revenue of 714.54 million yuan, representing a year-on-year increase of 10% to 18% [2]. - The expected net loss ranges from 60 million yuan to 45 million yuan, with a specific loss attributed to shareholders of 50.80 million yuan, reflecting a decline of 18.10% to 11.42% compared to the previous year [2]. - The net loss after excluding non-recurring items is projected to be 55.02 million yuan, indicating a decrease of 27.24% to 9.12% year-on-year [2]. - Basic earnings per share are expected to be a loss between 0.2454 yuan and 0.1841 yuan, compared to a loss of 0.2078 yuan per share in the previous year [2]. Business Segments - The digital painting business is expected to see a sales revenue growth of 20% to 25%, with significant growth in both domestic and overseas markets [3]. - The AI reading and writing smart notebooks and readers are projected to grow by 45% to 55% in sales revenue, with gross profit growth outpacing expense growth [3]. - The AI Koshian electronic blood pressure monitor is gaining market recognition, with substantial expected sales revenue growth [3]. R&D Investment - The company continues to invest heavily in R&D, with a year-on-year increase in R&D expenses [4]. - Investments are being made in cutting-edge technologies, including large model technology, bionic robotics, and olfactory recognition technology, which are still in the incubation stage and may not yield immediate financial benefits [4].

Core Viewpoint - The company Huashengchang is entering the AI glasses market through a strategic partnership, aiming to leverage its expertise in measurement instruments to develop industrial-grade AI glasses tailored to specific user needs [1][2][3]. Group 1: Strategic Initiatives - Huashengchang's subsidiary, Deep Sensing, is collaborating with Huawou and Huajing to establish Shenzhen Deepjing Intelligent Technology Co., focusing on AI glasses [1]. - The partnership structure is designed to incentivize internal employees and attract external talent, enhancing innovation and operational efficiency [2]. - The company aims to accelerate its strategic layout in AI glasses due to the maturity of the supply chain, with major players like Baidu and Xiaomi driving rapid development in components and solutions [2]. Group 2: Product Development Focus - Unlike consumer-grade AI glasses, Huashengchang is focusing on developing industrial-grade AI glasses that meet specific professional needs, such as remote diagnostics and measurement [3][4]. - The company recognizes the importance of customizing products based on downstream application scenarios, which presents a significant opportunity in the industrial sector [4]. - Huashengchang's existing expertise in measurement tools positions it well to capture industrial-grade AI glasses market share by leveraging its understanding of client needs [4]. Group 3: Future Vision and Ecosystem - The company envisions creating a next-generation measurement ecosystem, with AI glasses as a foundational element, integrating various wearable devices and measurement instruments [5][6]. - Huashengchang plans to expand its product matrix by developing new professional instruments and medical testing products, while deepening the integration of AI technology [7]. - The company's long-term vision includes re-engineering all its products using AI technology, indicating a commitment to innovation and adaptation in the evolving market landscape [8].

聚焦社会产业发展需求，优化计量服务。该局围绕蔬菜、农副产品等重点产业，精准发力，优化计量服 务。每年定期对辖区农贸市场开展周期检查活动，已为市场217家商铺提供上门检定服务，共检定电子 计价秤260余台，开展手机变砝码2200余人。同时，向商铺经营者宣传《集贸市场计量监督管理办 法》，增强经营者的法律意识。 为切实保障市场计量工作的精准性和公平性，新疆维吾尔自治区乌苏市市市场监管局强化党建引领，积 极践行"实干争先"理念，精准施策、靶向发力，以"三聚焦"推动计量服务高质量发展，为民生保障和产 业升级提供坚实支撑。 聚焦民生服务，提升计量惠民实效。该局聚焦民生计量保障，贯彻落实助企惠民政策，开放水表实验 室、天平砝码检定室等实验室，共享检定环境，助力企业计量精准。今年以来，共检定计量器具11800 余台。此外，对群众送检的家用计量器具（血压计、电子台秤等）做到能检尽检，告知检定结果，并解 答相关计量问题。为进一步加强民用"三表"计量监督管理，切实保障居民用水电气计量的准确性，维护 广大人民群众的合法权益，根据《自治区整治居民水电气计量不准确、收费不规范问题专项行动实施方 案》要求，乌苏市市场监督管理局于2025 ...